BNR - Burning Rock Biotech

...

Available for logged in users only.

The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.

• Burning Rock Biotech GAAP EPS of -$0.23, revenue of $17.5M
• Burning Rock's cancer detection blood test OverC gets breakthrough device status in China
• Burning Rock Biotech GAAP EPS of -$0.18, revenue of $20.2M
• Burning Rock Biotech GAAP EPS of -$0.26, revenue of $20.8M; reaffirms FY23 guidance
• Burning Rock Biotech GAAP EPS of -$0.31, revenue of $20.6M
• Burning Rock spikes on FDA breakthrough device designation for cancer test
• Burning Rock Biotech GAAP EPS of -$0.31 beats by $0.03, revenue of $21.74M misses by $0.32M
• Burning Rock Biotech stock gains ~18% after co affirms FY 2022 revenue guidance
• Burning Rock Biotech GAAP EPS of -$0.37 misses by $0.01, revenue of $19.5M misses by $2.94M
• Burning Rock Biotech announces $10M stock buyback plan
• Burning Rock Biotech gets EU's CE mark for its OverC cancer detection blood test
• Burning Rock Biotech GAAP EPS of -$0.39 misses by $0.01, revenue of $21.4M misses by $0.32M
• Burning Rock Biotech GAAP EPS of -$0.38, revenue of $23.12M
• Burning Rock reaffirms 2021 Revenue guidance of RMB500M
• Merck KGaA, Burning Rock collaborate on liquid-biopsy based CDx development
• Burning Rock Biotech misses on revenue
• Burning Rock inks collaboration agreement with IMPACT Therapeutics
• Burning Rock Biotech in red on widening net loss offset by growing revenue
• Burning Rock Biotech misses on revenue; updates full year guidance
• NanoVibronix, Intec Pharma leads healthcare gainers; Annovis Bio, Atreca among major losers